Table 2.
Study | Functional assessment | Outcome | Follow-up time (months) | Radiologic assessment | Outcome | Mean follow-up time (months) |
---|---|---|---|---|---|---|
Gangji, 2011 [11] | VAS | + | 24 | MRI | Delay to collapse: + | NA |
Lesquene | + | Delay to THR: ND | ||||
WOMAC | + | |||||
Zhao, 2012 [54] | HHS | + | 24 | MRI | Delay to collapse: + | NA |
Delay to THR: ND | ||||||
Sen, 2012 [45] | HHS | − | 24 | MRI, X-rays | Delay to THR: − | |
Koo, 1995 [24] | MAP | + | 13 | MRI, X-rays | Delay to collapse: ND | 24 |
Delay to THR: ND | ||||||
Neumayr, 2006 [38] | CHOHES | I | 27 | MRI, X-rays | Delay to THR: ND | CD group: 37.2 |
Control group: 36 | ||||||
Delay to collapse: ND | ||||||
Stulberg, 1991 [49] | HHS | + | 13 | MRI, X-rays | Delay to THR: + | 26.8 |
Chen , 2012 [9] | HHS | ND | 24 | MRI, X-rays | Delay to collapse: ND | NA |
SF-36 | ND | Delay to THR: ND | ||||
Lai, 2005 [26] | HHS | I | 24 | MRI, X-rays | Delay to collapse: + | 8 |
Delay to THR: + | ||||||
Lee, 2015 [27] | HHS | − | 24 | MRI, X-rays | Delay to collapse: ND | 24 |
WOMAC | − | 24 | Delay to THR: ND | |||
Hsu, 2010 [18] | HHS | − | 26 | MRI, X-rays | Progression: ND | NA |
MAP | – | Delay to THR: ND | ||||
WOMAC | – | |||||
SF-12 | – | |||||
Wang, 2008 [51] | HHS | − | 6.5 | MRI, X-rays | Progression: ND | 24.87–26.14 |
Kang, 2012 [23] | HHS | − | 15.75 | MRI, X-rays | Delay to collapse (+) | 62.5 |
Outcomes: (+) significant improvement, (−) no significant improvement; (ND) no difference, and (I) statistics not reported
MAP Multidimensional Assessment Pain Scale, WOMAC Western Ontario and McMaster Universities Arthritis, CHOHES Children’s Hospital Oakland Hip Evaluation Scale, HHS Harris Hip Scores, VAS visual analogue score, SF-36 Short-Form 36 Health Survey, SF-12 Short-Form 12 Health Survey